Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Elevated white blood cell count may predict risk of orbital implant exposure.

Bee YS, Lin MC, Sheu SJ, Ng JD.

Can J Ophthalmol. 2014 Feb;49(1):45-9. doi: 10.1016/j.jcjo.2013.08.013.

PMID:
24513356
2.

Primary implant placement with evisceration in patients with endophthalmitis.

Dresner SC, Karesh JW.

Ophthalmology. 2000 Sep;107(9):1661-4; discussion 1664-5.

PMID:
10964824
3.

Risk factors in endophthalmitis leading to evisceration or enucleation.

Tsai YY, Tseng SH.

Ophthalmic Surg Lasers. 2001 May-Jun;32(3):208-12.

PMID:
11371087
4.

Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.

Yoon JS, Lew H, Kim SJ, Lee SY.

Ophthalmology. 2008 Mar;115(3):566-572.e2. Epub 2007 Sep 14.

PMID:
17854900
5.

Enucleation with primary implant insertion for treatment of recalcitrant endophthalmitis and panophthalmitis.

Abel AD, Meyer DR.

Ophthal Plast Reconstr Surg. 2005 May;21(3):220-6.

PMID:
15942499
6.

Evisceration with primary implant placement in patients with endophthalmitis.

Tawfik HA, Budin H.

Ophthalmology. 2007 Jun;114(6):1100-3. Epub 2007 Jan 29.

PMID:
17258811
7.

Porous orbital implant exposure: the influence of surgical technique.

McElnea EM, Ryan A, Fulcher T.

Orbit. 2014 Apr;33(2):104-8. doi: 10.3109/01676830.2013.851706. Epub 2013 Nov 11.

PMID:
24215109
9.

Evisceration with Primary Orbital Implant in Fulminant Endophthalmitis/Panophthalmitis.

Tripathy D, Rath S.

Orbit. 2015;34(5):279-83. doi: 10.3109/01676830.2015.1078366. Epub 2015 Aug 26.

PMID:
26308681
10.

Comparing outcomes of enucleation and evisceration.

Nakra T, Simon GJ, Douglas RS, Schwarcz RM, McCann JD, Goldberg RA.

Ophthalmology. 2006 Dec;113(12):2270-5. Epub 2006 Sep 25.

PMID:
16996606
11.

Endophthalmitis caused by Pseudomonas aeruginosa.

Eifrig CW, Scott IU, Flynn HW Jr, Miller D.

Ophthalmology. 2003 Sep;110(9):1714-7.

PMID:
13129867
12.

The results of evisceration with primary porous implant placement in patients with endophthalmitis.

Park YG, Paik JS, Yang SW.

Korean J Ophthalmol. 2010 Oct;24(5):279-83. doi: 10.3341/kjo.2010.24.5.279. Epub 2010 Oct 5.

13.

Late exposure of the bioceramic orbital implant.

Wang JK, Lai PC, Liao SL.

Am J Ophthalmol. 2009 Jan;147(1):162-170.e1. doi: 10.1016/j.ajo.2008.05.001. Epub 2008 Jun 24.

PMID:
18571617
14.

[Evisceration and secondary enucleation with implantation following endophthalmitis].

Gaillard MC, Gianoli F, Spahn B.

J Fr Ophtalmol. 2005 Jun;28(6):618-22. French.

15.

Outcomes of orbital implants after evisceration and enucleation in patients with endophthalmitis.

Hui JI.

Curr Opin Ophthalmol. 2010 Sep;21(5):375-9. doi: 10.1097/ICU.0b013e32833b7a56. Review.

PMID:
20489621
16.
17.

Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration.

Alwitry A, West S, King J, Foss AJ, Abercrombie LC.

Ophthal Plast Reconstr Surg. 2007 Jan-Feb;23(1):11-5.

PMID:
17237682
18.

Primary implant placement with evisceration in patients with endophthalmitis.

Ozgur OR, Akcay L, Dogan OK.

Am J Ophthalmol. 2007 May;143(5):902-4. Epub 2006 Dec 20.

PMID:
17452189
19.

The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases.

Blaydon SM, Shepler TR, Neuhaus RW, White WL, Shore JW.

Ophthal Plast Reconstr Surg. 2003 Sep;19(5):364-71.

PMID:
14506421
20.

Enucleation and evisceration at a tertiary care hospital in a developing country.

Ababneh OH, AboTaleb EA, Abu Ameerh MA, Yousef YA.

BMC Ophthalmol. 2015 Sep 11;15:120. doi: 10.1186/s12886-015-0108-x.

Items per page

Supplemental Content

Write to the Help Desk